Effects of photodynamic therapy using hematoporphyrin monomethyl ether on experimental choroidal neovascularization

Photochemistry and Photobiology

Volumn 86, Issue 4, 2010, Pages 972-980

  Fan, Sijun ^a   Qiu, Haixia ^a   Huang, Houbin ^a   Gu, Ying ^a   Zeng, Jing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPORPHYRIN; HEMATOPORPHYRIN MONOMETHYL ETHER; PHOTOSENSITIZING AGENT;

ANIMAL; ARTICLE; BROWN NORWAY RAT; CHEMISTRY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; LASER; MALE; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; RAT; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HEMATOPORPHYRINS; LASERS; MALE; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, INBRED BN;

RATTUS;

EID: 77954413712     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2010.00757.x     Document Type: Article

References (53)

1. Buch, H., T. Vinding, M. La Cour N. V. Nielsen (2001) The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. Acta Ophthalmol. Scand. 79, 441 449.
2. Congdon, N., B. O'Colmain, C. C. Klaver, R. Klein, B. Muñoz, D. S. Friedman, J. Kempen, H. R. Taylor P. Mitchell (2004) Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122, 477 485. (Pubitemid 38456282)
3. Resnikoff, S., D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, G. P. Pokharel S. P. Mariotti (2004) Global data on visual impairment in the year 2002. Bull. World Health Organ. 82, 844 851.
4. Ferris, F. L., S. L. Fine L. Hyman (1984) Age related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol. 102, 1640 1642.
5. Schein, O. D., N. M. Bressler P. Price (2005) Photodynamic therapy with verteporfin: Observations on the introduction of a new treatment into clinical practice. Arch. Ophthalmol. 123, 58 63.
6. Comer, G. M., T. A. Ciulla, M. H. Criswell M. Tolentino (2004) Current and future treatment options for non-exudative and exudative age-related macular degeneration. Drugs Aging 21, 967 992.
7. Midena, E., E. Pilotto, P. P. Radin E. Convento (2004) Subthreshold transpupillary thermotherapy for subfoveal occult choroidal neovascularization secondary to age-related macular degeneration. Semin. Ophthalmol. 19, 25 28. (Pubitemid 39658406)
8. Soubrane, G. N. M. Bressler (2001) Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: Focus on clinical application of verteporfin photodynamic therapy. Br. J. Ophthalmol. 85, 483 495.
9. Danis, R. P., T. A. Ciulla, L. M. Pratt W. Anliker (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20, 244 250.
10. Brown, D. M., P. K. Kaiser, M. Michels, G. Soubrane, J. S. Heier, R. Y. Kim, J. P. Sy S. Schneider (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1432 1444.
11. Jo, N., C. Mailhos, M. Ju, E. Cheung, J. Bradley, K. Nishijima, G. S. Robinson, A. P. Adamis D. T. Shima (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am. J. Pathol. 168, 2036 2053.
12. Carvounis, P. E., A. C. Kopel M. S. Benz (2007) Retinal pigment epithelial tears following ranibizumab for exudative age-related macular degeneration. Am. J. Ophthalmol. 143, 504 505.
13. Tuñón, J., J. M. Ruiz-Moreno, J. L. Martín-Ventura, L. M. Blanco-Colio, O. Lorenzo J. Egido (2009) Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration. Surv. Ophthalmol. 54, 339 348.
14. Berenbaum, M. C., G. W. Hall A. D. Hoyes (1986) Cerebral photosensitization by haematoporphyrin derivative. Evidence for an endothelial site of action. Br. J. Cancer 53, 81 89.
15. Nelson, J. S., L. H. Liaw, A. Oresnstein, W. G. Roberts M. W. Berns (1988) Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorine, and phthalocyanine. J. Natl Cancer Inst. 80, 1599 1605.
16. Fingar, V. H., T. J. Wieman, S. A. Wiehle P. B. Cerrito (1992) The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52, 4919 4921.
17. Pauleikhoff, D., N. Bornfeld, V. P. Gabel, F. Holz H. Roider (2005) The position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists - Comments on the current therapy for neovascular AMD. Klin. Monbl. Augenheilkd 222, 381 388.
18. Axer-Siegel, R., R. Ehrlich, D. Weinberger, I. Rosenblatt, L. Shani, Y. Yassur, E. Priel M. Kramer (2004) Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatment. Am. J. Ophthalmol. 138, 602 607.
19. Fong, K. C., D. Thomas, K. Amin, D. Inzerillo S. E. Horgan (2008) Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularization secondary to punctuate inner choroidopathy. Eye 22, 528 533.
20. Chan, W. M., T. H. Lim, A. Pece, R. Silva N. Yoshimura (2010) Verteporfin PDT for non-standard indications - A review of current literature. Graefes Arch. Clin. Exp. Ophthalmol. 248, 613 626.
21. Choi, Y. H., S. H. Ko, S. J. Kim, W. Y. Lee, J. H. Park J. M. Lee (2005) Induction of cell death by photodynamic therapy with a new synthetic photosensitizer DH-I-180-3 in undifferentiated and differentiated 3T3-L1 cells. Biochem. Biophys. Res. Commun. 337, 1059 1064.
22. Haywood-Small, S. L., D. I. Vernon, J. Griffiths, J. Schofield S. B. Brown (2006) Phthalocyanine-mediated photodynamic therapy induces cell death and a G0/G1 cell cycle arrest in cervical cancer cells. Biochem. Biophys. Res. Commun. 339, 569 576.
23. Yamada, H., T. Arai, N. Endo, K. Yamashita, M. Nonogawa, K. Makino, K. Fukuda, M. Sasada T. Uchiyama (2005) Photodynamic effects of a novel pterin derivative on a pancreatic cancer cell line. Biochem. Biophys. Res. Commun. 333, 763 767.
24. Renner, M. W., M. Miura, M. W. Easson M. G. Vicente (2006) Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy. Anticancer Agents Med. Chem. 6, 145 157.
25. Xu, D. Y., W. H. Chen, H. Zhang N. C. Shen (1993) Hematoporphyrin 3- or 8-monomethyl ether: A promising candidate for tumor photodynamic therapy. J. Med. Coll. PLA 8, 406 409.
26. Chen, W. H., J. X. Yu, J. Z. Yao, W. D. Shen, J. F. Liu D. Y. Xu (2000) Pharmacokinetic studies on hematoporphyrin monomethyl ether: A new promising drug for photodynamic therapy of tumors. Chin. J. Laser Med. Surg. 9, 105 108.
27. Xu, D. Y., W. H. Chen, H. Zhang N. C. Shen (1993) Studies on a new drug for photodynamic therapy: Hematoporphyrin monomethyl ether. Chin. J. Laser Med. Surg. 2, 3 7.
28. Fu, Q. T., Y. Gu, F. G. Liu, J. G. Zhu, Y. Q. Sun A. Q. Liu (2000) Photosensitivity of HMME in vitro. Acta. Laser Biol. Sin. 9, 137 141.
29. Gu, Y., J. H. Li, K. Wang, Y. P. Jiang, J. Liang J. G. Zhu (1996) Preliminary clinical observation of HMME in PDT for PWS. Chin. J. Laser Med. Surg. 5, 201 204.
30. Song, K., B. H. Kong, X. Qu, L. Li Q. F. Yang (2005) Phototoxicity of Hemoporfin to ovarian cancer. Biochem. Biophys. Res. Commun. 337, 127 132.
31. Gu, Y., F. G. Liu, K. Wang, J. G. Zhu, J. Liang, Y. M. Pan J. H. Li (2001) A clinic analysis of 1,216 cases of port wine stain treated by photodynamic therapy. Chin. J. Laser Med. Surg. 10, 86 89.
32. Gu, Y., N. Y. Huang, J. Liang, Y. M. Pan F. G. Liu (2007) Clinical study of 1949 cases of port wine stains treated with vascular photodynamic therapy (Gu's PDT). Ann. Dermatol. Venereol. 134, 241 244.
33. Ding, X., Q. Z. Xu, F. G. Liu, P. Q. Zhou, Y. Gu, J. Zeng, J. An, W. D. Dai X. S. Li (2004) Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett. 216, 43 54.
34. Wei, Y. Q., B. H. Kong, K. Song, X. Qu, Q. Jin Q. F. Yang (2007) Involvement of mitochondria-caspase pathway in Hemoporfin-mediated cell death. Photochem. Photobiol. 83, 1319 1324.
35. Wang, Z. H. Liu (2005) The study of photodynamic therapy for corneal neovascularization. Chin. J. Laser Med. Surg. 14, 94 98.
36. Han, L. N., Y. Gu F. G. Liu (2006) Impact of laser power density on retinal and choroidal biological effect. Chin. J. Laser Med. Surg. 15, 89 92.
37. McMenamin, P. G. (2000) Optimal methods for preparation and immunostaining of iris, ciliary body and choroidal wholemounts. Invest. Ophthalmol. Vis. Sci. 41, 3043 3048.
38. Kramer, M., J. W. Miller, N. Michaud, R. S. Moulton, T. Hasan, T. J. Flotte E. S. Gragoudas (1996) Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 103, 427 438. (Pubitemid 26085897)
39. Dobi, E. T., C. A. Puliafito M. Destro (1989) A new model of experimental choroidal neovascularization in the rat. Arch. Ophthalmol. 107, 264 269.
40. Thomas, E. M. Langhoffer (1987) Closure of experimental subretinal neovascular vessels with dihematopophyrin ether augmented argon green laser photocoagulation. Photochem. Photobiol. 46, 881 886.
41. Miller, H. B. Miller (1993) Photodynamic therapy of subretinal neovascularization in the monkey eye. Arch. Ophthalmol. 111, 855 860.
42. Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2. Am. J. Ophthalmol. 131, 541 560.
43. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch. Ophthalmol. 119, 198 207.
44. Haimovici, R., M. Kramer, T. Flotte, J. Miller E. Gragoudas (1997) Localization of benzoporphyrin derivative in the rabbit eye. Curr. Eye Res. 16, 83 90.
45. Kim, R. Y., L. K. Hu, T. J. Flotte, E. S. Gragoudas L. H. Young (1997) Digital angiography of experimental choroidal melanomas using benzoporphyrin derivative. Am. J. Ophthalmol. 123, 810 816.
46. Shi, D. W., Y. Gu J. Zeng (2008) Retinal injury thresholds due to copper vapor laser with wavelength of 578.2 nm. Chin. J. Laser Med. Surg. 17, 1 4.
47. Schmidt-Erfurth, U., J. W. Miller, M. Sickenberg, H. Laqua, I. Barbazetto, E. S. Gragoudas, L. Zografos, B. Piguet, C. J. Pournaras, G. Donati, A. M. Lane, R. Birngruber, H. van den Berg, H. A. Strong, U. Manjuris, T. Gray, M. Fsadni N. M. Bressler (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study. Arch. Ophthalmol. 117, 1177 1187. (Pubitemid 29428826)
48. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials. TAP Report 1. Arch. Ophthalmol. 117, 1329 1345.
49. Obana, A., Y. Gohto, K. Kaneda, S. Nakajima T. Miki (2001) PDT to monkey CNV with ATX-S10 (Na): Inappropriateness of early laser irradiation for selective occlusion. IOVS 42, 2639 2645.
50. Sunderkoetter, C., K. Steinbrink, M. Goebeler, R. Bhardwaj C. Sorg (1994) Macrophages and angiogenesis. J. Leukoc. Biol. 55, 410 422.
51. Adams, A. P., D. T. Shima, K. T. Yeo, L. F. Brown, B. Berse, P. A. D'Amore J. Folkman (1993) Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 193, 631 638.
52. Vinores, S. A., A. I. Youssri, J. D. Luna, Y. S. Chen, S. Bhargave, M. A. Vinores, C. L. Schoenfeld, B. Peng, C. C. Chan, W. LaRochelle, W. R. Green P. A. Campochiaro (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol. Histochem. 12, 99 109.
53. Ogata, N., M. Matsushima, Y. Takada, T. Tobe, K. Takahashi, X. Yi, C. Yamamoto, H. Yamada M. Uyama (1996) Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr. Eye Res. 15, 1008 1018. (Pubitemid 26360037)